Nikolay Grechko

ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer

Bradley J. Monk, Robert L. Coleman, Keiichi Fujiwara et al. · International Journal of Gynecological Cancer · 2021 · 81 citations · Full text

Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment

Nikolay Grechko, Viera Skarbová, Monika Tomaszewska‐Kiecana et al. · Cancer Chemotherapy and Pharmacology · 2021 · 17 citations · Full text

ZUMA-22: A phase 3, randomized controlled study of axicabtagene ciloleucel (axi-cel) versus standard-of-care therapy in patients with relapsed or refractory (R/R) follicular lymphoma (FL).

Ian W. Flinn, Caron A. Jacobson, Loretta J. Nastoupil et al. · Journal of Clinical Oncology · 2023 · 11 citations

A phase 1, open-label, drug–drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors

Mingxiang Liao, Krzysztof Jeziorski, Monika Tomaszewska‐Kiecana et al. · Cancer Chemotherapy and Pharmacology · 2021 · 10 citations · Full text